Schedule 13G ownership disclosure

NEUROONE MEDICAL TECHNOLOGIES Corp

Security class unavailable · CUSIP: 64130M100

Event date: 2018-07-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
683,850
Percent of class
6.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001695690-19-000001
Form type
SC 13G
Filer
FundRx NeuroOne Fund, a series of FundRx Master Fund I, LLC
CIK
CIK 1695690
Filed
Jan 15, 2019
Reporting period
Jul 06, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub